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     Acute lymphoblastic leukemia (ALL) is the most common cancer among children. Despite recent 
treatment advances, about 80 percent of patients indicate resistance to treatment and the relapse remains a 
significant clinical problem. Apoptotic-resistant leukemia cells exhibit an unusual response to the NF-κB 
pathway; therefore, inhibiting this pathway can sensitize resistant cells to treatment. IKK-NF-kappaB 
signaling is an important factor in carciogenesis and a potential target for cancer treatment. Therefore, in 
this study, the mRNA expression of targets of NF-κB signaling including IKKalpha, IKKbeta and also 
NF-κB were analyzed, using the real time-PCR in the face of the combined effect of Curcuma longa and 
prednisolone in the ALL cell line of NALM-6. Results of the study showed significant downregulation of 
three genes after combination Curcuma longa (5 µg/ml) and prednisolone (1 μM) in comparison with the 
single agents alone. These findings unveiled the synergistic effect of Curcuma longa and prednisolone on 
IKKα and IKKβ downregulation and NF-κB inhibition that can be considered as a new approach in the 
ALL treatment of resistance to chemotherapy. 
 
Keywords: Acute lymphoblastic leukemia; Curcuma longa; prednisolone; NF-κB signaling 
 
INTRODUCTION 
     Different types of leukemia are the most 
common cancer in children, and among them, 
acute lymphoblastic leukemia (ALL) is the most 
common subtype, with about 25% of childhood 
tumors [1]. The malignancy is associated with 
uncontrolled proliferation of lymphoid 
progenitors in the bone marrow as well as with 
the accumulation of malignant lymphoblasts in 
bone marrow and peripheral blood. Modern 
chemotherapy regimens can effectively treat 
more than 80% of ALL cases [1]. The vast 
majority of recurrence occurs due to the failure 
of therapeutic medications to the complete 
elimination of the major leukemic clone and 
subsequently the spread of the disease [2]. 
Investigating the resistance of cancer cells to 
chemotherapy drugs has opened a new research 
topic. Efforts to understand the mechanisms of 
resistance to treatment have led to significant 
improvements over our understanding of 
signaling pathways involved in the survival of 
cancer cells. Now that many survival pathways  
 
have been identified, one of the challenges ahead 
is the discovery and development of molecular 
factors that have the potential to increase the 
sensitivity of tumor cells to chemotherapy. 
Among the signaling pathways that influence on 
the survival of the tumor, the NF-κB pathway 
has received considerable attention [3]. When 
cells are exposed to a suitable stimulus, a triple 
IKK complex consisting of IKKα, IKKβ, and 
IKKγ causes phosphorylation of IκB (NF-κB 
inhibitor protein), which leads to the release of 
NF-κB and subsequently activate genes 
expression [4,5]. IKKβ knockout mice have 
indicated fetal death and an incomplete response 
to inflammatory cytokines [6], and IKKα 
knockout mice have showed incomplete 
 




reproduction and morphogenesis [7]. 
Additionally, IKKα is involved in a variety of 
biological functions, including apoptosis, tumor 
suppression, immune system, cell proliferation. 
Totally, both IKKα and IKKβ are critical to the 
expression of the genes through NF-κB.  
Accordingly, in this study, the effect of Curcuma 
longa extract (previously examined for cytotoxic 
effects) was evaluated alone as an inhibitor of 
IKKα/β and in combination with prednisolone as 
a sensitizer to the drug in ALL cells. 
 
MATERIALS AND METHODS  
Chemicals  
     Prednisolone was purchased from Sigma-
Aldrich (Sigma-P6004) and dissolved in sterile-
filtered Dimethyl sulfoxide (DMSO) and 
aliquoted and stored at -20 °C. RPMI 1640 
medium (Gibco), FBS (Gibco), RNA extraction 
kit (GeneAll, Korea), cDNA synthesis kit 
(Thermo Scientific, USA), and sybr master mix 
(Takara, Japan) were also purchased. 
Plant extract 
     The extract was obtained from the Curcuma 
longa roots which was prepared at the 
Traditional Medicine and Materia Medical 
Research Center, Shahid Beheshti University of 
Medical Sciences, Tehran, Iran. Total extract 
was obtained through maceration for 24 h with 
continuous shaking at room temperature. The 
filtrate was evaporated to dryness and used for 
evaluation. A stock solution was prepared with a 
concentration of 100 mg/ml in DMSO and was 
stored at -20 °C. 
Cell culture 
     NALM-6 cells as acute lymphoblastic 
leukemia cells were purchased from the Pasteur 
Institute of Iran, Tehran. Cells were cultured in 
RPMI 1640 medium, containing 10% FBS and 
1% penicillin at 37 °C with 5% CO2. 
RNA isolation and quantitative real-time PCR 
     The Cells )3×10
5
 cells/ml) were treated with 
different concentrations of prednisolone and 
Curcuma longa extract and were incubated for 
48 h, and total RNA was extracted from each 
well using the Hybrid-R RNA purification kit 
(GeneAll, Korea) according to the 
manufacturer’s instructions. The quantity of the 
RNA samples was analyzed by UV-
spectroscopy (NanoDrop TM 2000 
Spectrophotometer, Thermo Scientific, USA) at 
260 and 280 nm and the quality of extracted 
RNA was tested by the 1% agarose gel 
electrophoresis. RNA was reverse transcribed to 
first-strand cDNA using the RevertAid First 
Strand cDNA Synthesis Kit (Thermo Scientific, 
USA), following the manufacturer’s instructions. 
All the sequence of the primers are shown in 
Table 1. Real-time PCR analysis was performed 
using SYBR Premix Ex Taq (Tli RNase H Plus) 
kit (Takara Biomedical Technology, Japan) in 
Applied Rotor-Gene Q Real Time PCR System 
(Qiagen, Valencia, CA). The expression of ABL 
gene was utilized as an endogenous control to 
normalize the expression of the target genes. 
Melting curve analysis of IKKα, IKKβ, NF-κB 
and ABL showed a single peak. The mean Ct of 
the target genes was calculated from triplicate 
measurements and then normalized with the 
mean Ct of ABL gene. Data extraction was 
executed using the Rotor-Gene Q series software 
v. 2.0.2, and the Pfaffl method was used to 
calculate the relative expression of each gene 
[8]. 
 
















Statistical analysis  
     The SPSS Statistics version 23 software was 
used for data analysis. The one-way ANOVA 
and post hoc Tukey multiple comparison tests  
 
were used in the comparison between more than 
2 groups. Results are presented as means ± SD. 
P < 0.05 was considered significant.
RESULTS  
Effect of Curcuma longa extract and 
prednisolone combination on the IKKα 
expression in NALM-6 cells 
     In this study, doses of 1, 5, 10, and 15 μg/ml 
of the extract with 1 μM prednisolone alone and 
in combination with the drug were evaluated 
over 48 hours of incubation to determine the 
expression changes of the IKKα gene. Our 
results indicated that Curcuma longa and 
prednisolone can reduce the expression of IKKα  
gene in individual doses and synergy. 
Concurrent use of Curcuma longa extract and 
prednisolone in doses of 1, 5 and 10 μg/ml of 
extract and 1 μM prednisolone significantly 
reduced the expression of IKKα gene compared 
to the use of each drug alone. The concentration 
of 1 μg/ml extract and 1 μM drug resulted in a 
1.58-fold decrease in IKKα gene expression 
compared to control. Additionally, synergy of 5 
and 10 μg/ml extract and 1 μM drug reduced the 




Figure 1. Effect of various concentrations of Curcuma longa (1, 5, 10, 15 µg/ml) combined with Prednisolone (1 μM) on IKKα 
mRNA expression levels in NALM-6 cells. Each bar represents the mean±SD (n=3). P<0.05 (one way ANOVA and post hoc 
Tukey multiple comparison test).  
 
 
Effect of Curcuma longa extract and 
prednisolone combination on the IKKβ 
expression in NALM-6 cells 
     In this study, doses of 1, 5, 10, and 15 μg/ml 
of the extract with 1 μM prednisolone alone and 
in combination with the drug were evaluated 
over 48 hours of incubation to determine the 
expression changes of the IKKβ gene. This 
study's results indicated that Curcuma longa and  
prednisolone can reduce the expression of IKKβ 
gene in individual doses and synergy. 
Concurrent use of Curcuma longa extract and 
prednisolone in doses of 1, 5 and 10 μg/ml of 
extract and 1 μM prednisolone significantly 
reduced the expression of IKKβ gene compared 
to the use of each drug alone. The concentration 
of 5 μg/ml extract and 1 μM drug resulted in a 
1.58-fold decrease in IKKβ gene expression 
compared to control (Figure 2).  
 
 





Figure 2. Effect of various concentrations of Curcuma longa (1, 5, 10, 15 µg/ml) combined with Prednisolone (1 μM) on IKKβ 
mRNA expression levels in NALM-6 cells. Each bar represents the mean±SD (n=3). P<0.05 (one way ANOVA and post hoc 
Tukey multiple comparison test).  
 
Effect of Curcuma longa extract and 
prednisolone combination on the NF-κB 
expression in NALM-6 cells 
     In this study, doses of 1, 5, 10 and 15 μg/ml 
extract with 1 μM prednisolone alone and also in 
combination with the drug were evaluated for 48 
hours incubation to determine the rate of 
expression of NF-κB gene expression. The  
results indicated that Curcuma longa and 
prednisolone can reduce the expression of NF-
κB gene in individual doses and synergy.  
 
Concurrent use of Curcuma longa extract and 
prednisolone in doses of 5 and 10 μg/ml of 
extract and 1 μM prednisolone significantly 
reduced the expression of NF-κB gene compared 
to the use of each drug alone. The concentration 
of 5 μg/ml extract and 1 μM drug resulted in a 
1.25-fold decrease in NF-κB gene expression 
compared to control. Also, synergy of 10 μg/ml 
extract and 1 μM drug reduced the NF-κB gene 




Figure 3. Effect of various concentrations of Curcuma longa (1, 5, 10, 15 µg/ml) combined with Prednisolone (1 μM) on NF-κB 
mRNA expression levels in NALM-6 cells. Each bar represents the mean±SD (n=3). P<0.05 (one way ANOVA and post hoc 
Tukey multiple comparison test).  
 
DISCUSSION  
     The present study investigated expression 
changes of IKKα, IKKβ and NF-κB genes on the 
NALM-6 and  REH cells after treatment with 
Curcuma longa extract and prednisolone in 
individual doses and synergy. The results of the 
synergy of the extract and drug on the REH cell 
line indicated no significant alteration of these 
genes; therefore, the results of this cell line were 
 




not included in this report. The investigation of 
the synergistic effect of the extract and drug on 
the NALM-6 cell line was significant in some 
concentrations, especially 5 μg/ml extract and 1 
μM drug. Since, apoptotic-resistant leukemia 
cells exhibit an unusual response to the NF-kB 
pathway, inhibiting this pathway can sensitize 
resistant cells to treatment. Totally, the IKK-NF-
kappaB signaling pathway is considered as an 
important factor in carcinogenesis and a 
potential target for cancer treatment. Inhibition 
of this pathway in conjunction with inhibition of 
blast proliferation will have a double effect on 
the control of this malignancy. Over the past 
decade, genetic manipulation of NF-κB 
signaling and the development of IKK inhibitors 
have improved the treatment of inflammatory 
and autoimmune diseases [9]. Clinical studies 
have suggested IKKα/β as a therapeutic target  
for inhibiting NF-κB activity in a variety of 
cancers [10], but translating this target into 
clinical treatment is much more difficult than 
expected by researchers. Although the specific 
inhibitor of IKKα/b has not been introduced yet, 
the ideal inhibitor for the elimination of nuclear 
IKK function in a particular disease should be 
designed to minimize systemic toxicity, and may 
offer more effective therapeutic treatment for 
cancer treatment [11]. Herbal compounds, such 
as Curcuma longa, can reduce the side effects of 
the medication in combination with lower doses 
of chemotherapy drugs while these combinations 
can also inhibit the various signaling pathways. 
 
CONCLUSION  
     In summary, the present study analyzed the 
expression of IKKα, IKKβ and NF-κB genes in 
the face of the combined effect of Curcuma  
longa extract with prednisolone, and the results 
showed a positive effect of this synergy. Further 
investigations are required on other ALL cell 
lines and on the level of protein expression. 
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